Measuring head and neck cancer symptom burden: The development and validation of the M. D. Anderson symptom inventory, head and neck module

Head and Neck

Volumn 29, Issue 10, 2007, Pages 923-931

  Rosenthal, David I ^a   Mendoza, Tito R ^a   Chambers, Mark S ^a   Asper, Joshua A ^a   Gning, Ibrahima ^a   Kies, Merrill S ^a   Weber, Randal S ^a   Lewin, Jan S ^a   Garden, Adam S ^a   Ang, K Kian ^a   Wang, Xin S ^a   Cleeland, Charles S ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Head and neck cancer; MDASI; Symptom burden; Symptom severity; Validation

Indexed keywords

ADULT; ARTICLE; CANCER PATIENT; CONSTRUCT VALIDITY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DYSPHAGIA; FATIGUE; FEMALE; HEAD AND NECK CANCER; HUMAN; M.D. ANDERSON SYMPTOM INVENTORY; MAJOR CLINICAL STUDY; MALE; MASTICATION; MOUTH PAIN; MUCUS; PRIORITY JOURNAL; RELIABILITY; SCORING SYSTEM; SORE THROAT; SYMPTOMATOLOGY; VALIDATION PROCESS; XEROSTOMIA; COST OF ILLNESS; CROSS-SECTIONAL STUDY; HEAD AND NECK TUMOR; HOSPITALIZATION; LARYNX DISORDER; MIDDLE AGED; MOUTH ULCER; MUCOSA INFLAMMATION; PAIN; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REPRODUCIBILITY; TASTE DISORDER; VALIDATION STUDY;

COST OF ILLNESS; CROSS-SECTIONAL STUDIES; DEGLUTITION DISORDERS; FATIGUE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MASTICATION; MIDDLE AGED; MUCOSITIS; ORAL ULCER; PAIN; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TASTE DISORDERS; VOICE DISORDERS; XEROSTOMIA;

EID: 38449084887     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.20602     Document Type: Article

References (30)

1. List MA, Bilir SP. Functional outcomes in head and neck cancer. Semin Radiat Oncol 2004;14:178-189.
2. Ringash J, Bezjak A. A structured review of quality of life instruments for head and neck cancer patients. Head Neck 2001;23:201-213.
3. Jones HA, Hershock D, Machtay M, et al. Preliminary investigation of symptom distress in the head and neck patient population. Am J Clin Oncol 2006;29:158-162.
4. Food and Drug Administration, U.S. Department of Health and Human Services, Rockville, Maryland. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims, Draft guidance, February 2006.
5. Dworkin RH, Turk DC, Farrar JT, et al. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 2005;113:9-19.
6. Cleeland CS, Mendoza TR, Wang XS, et al. Assessing symptom distress in cancer patients: the M. D. Anderson Symptom Inventory. Cancer 2000;89:1634-1646.
7. Fadol A, Kernicki J, Symes L, et al. Reliability and validity testing of the M. D. Anderson Symptom Inventory-Heart Failure (MDASI-HF): a pilot study of an evaluative instrument for symptom identification in cancer patients with concurrent heart failure. Presented at the Heart Failure Society Meeting, Seattle, September 2005.
8. Armstrong TS, Cohen MZ, Eriksen L, Cleeland C. Content validity of self-report measurement instruments: an illustration from the development of the Brain Tumor Module of the M. D. Anderson Symptom Inventory. Oncol Nurs Forum 2005;32:669-676.
9. Armstrong TS, Mendoza T, Gring I, et al. Validation of the M. D. Anderson Symptom Inventory Brain Tumor Module (MDASI-BT). J Neurooncol 2006;80:27-35.
10. http://ctep.cancer.gov/forms/CTCAEv3.pdf.
11. Lynn MR. Determination and quantification of content validity. Nurs Res 1985;5:382-385.
12. Serlin RC, Mendoza TR, Nakamura Y, Edwards KR, Cleeland CS. When is cancer pain mild moderate or severe? Pain 1995;61:277-284.
13. Mendoza TR, Wang XS, Cleeland CS, et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999;85:1186-1196.
14. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982;5:649-655.
15. Ware JE, Kosinski M, Keller SD. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
16. Aldenderfer MS, Blashfield RK. Cluster analysis. London: Sage; 1984. 88 pp.
17. Ward JH Jr. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963;58:236-244.
18. Harman HH. Modern factor analysis, 2nd ed. Chicago: University of Chicago Press; 1967. 474 pp.
19. Nunnaly JC, Bernstein IH. Psychometric theory, 3rd ed. New York: McGraw-Hill; 1994. 752 pp.
20. Vokes EE, Kies MS, Haraf DJ, et al. Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer. J Clin Oncol 2000;18:1652-1661.
21. Finizia C, Hammerlid E, Westin T, et al. Quality of life and voice in patients with laryngeal carcinoma: a post-treatment comparison of laryngectomy (salvage surgery) versus radiotherapy. Laryngoscope 1998;108:1566-1573.
22. Herranz J, Gavilan J. Psychosocial adjustment after laryngeal cancer surgery. Ann Otol Rhinol Laryngol 1999;108:990-997.
23. Cleeland CS, Reyes-Gibby CC. When is it justified to treat symptoms? Measuring symptom burden. Oncology 2002;16(9, Suppl 10):64-70.
24. List MA, D'Antonio LL, Cella DF, et al. The performance status scale for head and neck cancer patients and the Functional Assessment of Cancer Therapy-Head and Neck (FACT-H&N) scale: a study of utility and validity. Cancer 1996;77:2294-2301.
25. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2001;50:695-704.
26. Chen AY, Frankowski R, Bishop-Leone J, et al. The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory. Arch Otolaryngol Head Neck Surg 2001;127:870-876.
27. Laverick S, Lowe D, Brown JS, Vaughan ED, Rogers SN. The impact of neck dissection on health-related quality of life. Arch Otolaryngol Head Neck Surg 2004;130:149-154.
28. Abendstein H, Nordgren M, Boysen M, et al. Quality of life and head and neck cancer: a 5-year prospective study. Laryngoscope 2005;115:2183-2192.
29. Anderson KO, Giralt SA, Neumann JL, et al. Symptom assessment following autologous transplantation: relation of symptom severity to laboratory measures. American Society of Hematology 45th Annual Meeting and Exposition, San Diego, CA, December 2003. Abstract 3672.
30. http://www.rtog.org/members/protocols/0435/0435.pdf.